Skip to Content

APO C300 (Carbamazepine Extended-Release 300 mg)

Pill with imprint APO C300 is White / Green, Capsule-shape and has been identified as Carbamazepine Extended-Release 300 mg. It is supplied by Apotex Corp..

Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; schizoaffective disorder; epilepsy; cluster-tic syndrome (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO C300

Carbamazepine extended-release 300 mg APO C300
Carbamazepine extended-release 300 mg APO C300
Carbamazepine extended-release 300 mg APO C300

Carbamazepine Extended-Release

Imprint:
APO C300
Strength:
300 mg
Color:
White / Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dibenzazepine anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
National Drug Code (NDC):
60505-2807

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide